Don Smith

FYI:

Technical Electronic Product Radiation Safety Standards Committee.


This notice announces a forthcoming meeting of a public advisory committee of the Food and Drug Administration (FDA). The meeting will be open to the public.

Name of Committee Technical Electronic Product Radiation Safety Standards Committee
Date and Time The meeting will be held on the following dates:

May 22, 2002 8:30 AM - May 22, 2002 5:00 PM

Location Hilton Washington DC North/Gaithersburg, Salons A and B
620 Perry Parkway
Gaithersburg, MD

Hotel Accommodations A block of sleeping rooms has been reserved at the Hilton Washington DC North/Gaithersburg, 620 Perry Parkway, Gaithersburg, MD (phone: 301-977-8900) for arrival on May 21, 2002 and departure on May 22, 2002. Rooms not reserved by April 29, 2002 will be released back to the hotel. Please reference FDA’s Technical Electronic Product Radiation Safety Standards Committee (TEPRSSC) when making your reservation.

Disability Accommodations FDA welcomes the attendance of the public at its advisory committee meetings and will make every effort to accommodate persons with physical disabilities or special needs. If you require special accommodations due to a disability, please contact AnnMarie Williams, Conference Management Staff, at 301-594-1283, ext. 113, at least 7 days in advance of the meeting.
Contact Information Orhan H. Suleiman, Center for Devices and Radiological Health (HFZ-240), Food and Drug Administration, 1350 Piccard Dr., Rockville, MD 20850, 301-594-3332, or FDA Advisory Committee Information Line, 1-800-741-8138 (301-443-0572 in the Washington, DC area), code 12399. Please call the Information Line for up-to-date information on this meeting.

Agenda. The committee will hear an informal review of ongoing activities associated with electronic products. Following the overview, FDA will discuss its concern about radiation doses associated with x-ray computed tomography (CT), and its current thinking about amending the U.S. performance standard for x-ray CT imaging procedures. Specifically FDA will address possible requirements for: (1) definition and standardization of CT terminology; (2) display of an index of patient radiation dose that could be automatically recorded within a facility quality assurance program; (3) automatic exposure control through modulation of x-ray tube output according to patient dimensions; and (4) limitation of the x-ray field size to that needed for image formation.

In the afternoon, FDA will discuss proposed amendments to the U.S. performance standard for sunlamp products and certain initiatives of international standards organizations concerning sunlamp products. In the final session, FDA will be considering mandatory standards for x-ray security screening systems; FDA will discuss public health considerations regarding these systems that use ionizing radiation.

Background information on the discussion topics will be posted under the Technical Electronic Products Radiation Safety Standards Committee (TEPRSSC) Docket site at http://www.fda.gov/ohrms/dockets/ac/acmenu.htm. (Click on the year 2002 and scroll down to TEPRSSC.)

Procedure Interested persons may present data, information, or views, orally or in writing, on issues pending before the committee. Written submissions may be made to the contact person by May 10, 2002. Oral presentations from the public will be scheduled between approximately 9:45 a.m. and 10:15 a.m., and between 3:15 p.m. and 4 p.m. Time allotted for each presentation may be limited. Those desiring to make formal oral presentations should notify the contact person before May 10, 2002, and submit a brief statement of the general nature of the evidence or arguments they wish to present, the names and addresses of proposed participants, and an indication of the approximate time requested to make their presentation.
Persons attending FDA's advisory committee meetings are advised that the agency is not responsible for providing access to electrical outlets.

Notice of this meeting is given under the Federal Advisory Committee Act (5 U.S.C. app. 2).


The "key" statement of interest to the indoor tanning industry is:

"In the afternoon, FDA will discuss proposed amendments to the U.S. performance standard for sunlamp products and certain initiatives of international standards organizations concerning sunlamp products."

[Note: What we don't know is which of the "certain initiatives of international standards organizations concerning suinlamp products" will be presented to TEPRSSC. Therefore, we must be prepared for ALL eventualities.]

I'll be staying at the Washington DC Hilton (North) and will arrive on Tuesday afternoon, May 21, 2002.

Call me (1-520-975-0180) if you want to discuss this issue.

Don

PS: There is no information available (today) on the link above. FDA has a history of posting this information the day of the meeting which, I think you will agree, makes it hard to prepare comments.



[ This Message was edited by: Don Smith on 2002-04-12 08:16 ][ This Message was edited by: Don Smith on 2002-04-13 08:56 ]

tangirl

Don - Thanks for providing us with this information.

To all salon owners: We need to put these meetings on our list of things to attend right along with trade shows.

MJ

Exactly.. Tangirl..
we should be more involved and not expect someone else to cover or a$$es..
However, If I had to pick one person to represent us as a whole .. It would be THE DON.
THANKS FOR YOUR EFFORTS DON.
MJ